Boston Scientific
BSX • NYSE
Boston Scientific is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Michael F. Mahoney, with a market cap of $110.60B.
CEOMichael F. Mahoney
Market Cap$110.60B
Medical - Devices
Healthcare
Employees48.0K
Websitebostonscientific.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Boston Scientific
Date
Wednesday, April 22, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.79
Revenue Estimate
$5.2B
Earnings History
Past 12 earnings reports for Boston Scientific
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q4 2025 | $0.80Est: $0.78 | +2.6% | $5.3BEst: $5.3B | +0.2% |  10-K |
| Oct 22, 2025 | Q3 2025 | $0.75Est: $0.71 | +5.6% | $5.1BEst: $5.0B | +1.9% | 10-Q |
| Jul 23, 2025 | Q2 2025 | $0.75Est: $0.72 | +4.2% | $5.1BEst: $4.9B | +3.5% | 10-Q |
| Apr 23, 2025 | Q1 2025 | $0.75Est: $0.67 | +11.9% | $4.7BEst: $4.6B | +2.0% | 10-Q |
| Feb 5, 2025 | Q4 2024 | $0.70Est: $0.66 | +6.1% | $4.6BEst: $4.4B | +3.2% | 10-K |
| Oct 23, 2024 | Q3 2024 | $0.63Est: $0.59 | +6.8% | $4.2BEst: $4.0B | +4.2% | 10-Q |
| Jul 24, 2024 | Q2 2024 | $0.62Est: $0.58 | +6.9% | $4.1BEst: $4.0B | +2.5% | 10-Q |
| Apr 24, 2024 | Q1 2024 | $0.56Est: $0.51 | +9.8% | $3.9BEst: $3.7B | +4.5% | 10-Q |
| Jan 31, 2024 | Q4 2023 | $0.55Est: $0.51 | +7.8% | $3.7BEst: $3.6B | +3.8% | 10-K/A |
| Oct 26, 2023 | Q3 2023 | $0.50Est: $0.48 | +4.2% | $3.5BEst: $3.5B | +1.6% | — |
| Jul 27, 2023 | Q2 2023 | $0.53Est: $0.49 | +8.2% | $3.6BEst: $3.5B | +2.8% | — |
| Apr 26, 2023 | Q1 2023 | $0.47Est: $0.43 | +9.3% | $3.4BEst: $3.2B | +7.2% | — |